Not Recruiting

Provided below is a list of the clinical trials that are currently in progress to evaluate new mesothelioma treatment protocols. Please note that the enrollment period for the following mesothelioma studies has concluded and no new participants are being recruited at this time.
The purpose of these studies is to determine both the safety and effectiveness of new mesothelioma drugs and treatment therapies. Click on a link to learn more about a study and to get recent update information.

• Nintedanib (BIBF 1120) in Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  January 22, 2015

  Status:

  Active, not recruiting

• Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

  Conditions:

  Unresectable Pleural or Peritoneal Malignant Mesothelioma

  Last Updated:

  January 16, 2015

  Status:

  Active, not recruiting

• Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

  Conditions:

  Epithelioid Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatoid Mesothelioma; Stage II Pleural Mesothelioma; Stage III Pleural Mesothelioma; Stage IV Pleural Mesothelioma

  Last Updated:

  January 9, 2015

  Status:

  Active, not recruiting

• Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  December 9, 2014

  Status:

  Active, not recruiting

• SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  December 5, 2014

  Status:

  Active, not recruiting

• Response Evaluation in Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  November 27, 2014

  Status:

  Active, not recruiting

• Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  November 24, 2014

  Status:

  Active, not recruiting

• A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  November 19, 2014

  Status:

  Active, not recruiting

• Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)

  Conditions:

  Lung Cancer; Mesothelioma

  Last Updated:

  November 7, 2014

  Status:

  Active, not recruiting

• Autologous Redirected RNA Meso-CIR T Cells

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  October 13, 2014

  Status:

  Active, not recruiting

• Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  September 1, 2014

  Status:

  Active, not recruiting

• Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

  Conditions:

  Mesothelioma

  Last Updated:

  August 12, 2014

  Status:

  Active, not recruiting

• Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

  Conditions:

  Pleural Mesothelioma; Peritoneal Mesothelioma

  Last Updated:

  July 17, 2014

  Status:

  Active, not recruiting

• Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

  Conditions:

  Breast Cancer; Colorectal Cancer; Lung Cancer; Malignant Mesothelioma; Prostate Cancer; Psychosocial Effects of Cancer and Its Treatment; Thymoma and Thymic Carcinoma

  Last Updated:

  May 2, 2014

  Status:

  Active, not recruiting

• Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  March 4, 2014

  Status:

  Active, not recruiting

• Tomotherapy Treatment for Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  March 4, 2014

  Status:

  Active, not recruiting

• Dasatinib in Resectable Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  February 24, 2014

  Status:

  Active, not recruiting

• A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  February 7, 2014

  Status:

  Active, not recruiting

• Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  January 3, 2014

  Status:

  Active, not recruiting

• High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

  Conditions:

  Breast Cancer; Endometrial Cancer; Malignant Mesothelioma

  Last Updated:

  November 5, 2013

  Status:

  Active, not recruiting

• ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  November 5, 2013

  Status:

  Active, not recruiting

• Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  September 19, 2013

  Status:

  Active, not recruiting

• Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  August 6, 2013

  Status:

  Active, not recruiting

• S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 16, 2013

  Status:

  Active, not recruiting

• NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  January 28, 2013

  Status:

  Active, not recruiting

• Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

  Conditions:

  Soft Tissue Sarcoma; Mesothelioma

  Last Updated:

  November 7, 2012

  Status:

  Active, not recruiting

• A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 20, 2012

  Status:

  Active, not recruiting

• Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  January 20, 2012

  Status:

  Active, not recruiting

• Gene Therapy for Pleural Malignancies

  Conditions:

  Pleural Mesothelioma; Metastatic Pleural Effusions

  Last Updated:

  September 29, 2010

  Status:

  Active, not recruiting

• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

  Conditions:

  Cancer

  Last Updated:

  August 7, 2010

  Status:

  Active, not recruiting

• Sorafenib in Previously Treated Malignant Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  August 3, 2009

  Status:

  Active, not recruiting

• Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 11, 2009

  Status:

  Active, not recruiting

• Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  April 21, 2009

  Status:

  Active, not recruiting

• Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  February 6, 2009

  Status:

  Active, not recruiting